Eckert & Ziegler SE (BIT:1EUZ)

Market Cap	975.53M -10.9%
Revenue (ttm)	311.96M +5.4%
Net Income	48.76M +46.5%
EPS	0.78 +46.5%
Shares Out	n/a
PE Ratio	20.01
Forward PE	18.81
Dividend	0.17 (1.17%)
Ex-Dividend Date	Jun 19, 2025

Volume	n/a
Average Volume	22
Open	n/a
Previous Close	15.68
Day's Range	n/a
52-Week Range	13.84 - 22.83
Beta	n/a
RSI	54.88
Earnings Date	Mar 26, 2026

About Eckert & Ziegler SE

Eckert & Ziegler SE manufactures and sells isotope technology components in Europe, North America, Asia, and internationally. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds based on iodine-125; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of choroidal melanomas; brain seed, HDR and brachytherapy; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceu...

• Industry: Industrial Inorganic Chemicals
• Founded: 1992
• Employees: 1,116
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1EUZ

Financial Performance

In 2025, Eckert & Ziegler SE's revenue was 311.96 million, an increase of 5.45% compared to the previous year's 295.85 million. Earnings were 48.76 million, an increase of 46.54%.